Healthcare Analytical Testing Services Market

The global healthcare analytical testing services market is expected to grow from USD 7,750 million in 2026 to USD 12,470 million by 2031, at a 10% CAGR during the forecast period. Market growth is driven by rising demand for analytical testing across pharmaceutical, biotechnology, food, environmental, diagnostic, and consumer applications, supported by increasing quality, safety, and regulatory requirements. The market is competitive, with established players expanding their service portfolios and geographic reach.

As of 2025, the key companies operating in the global healthcare analytical testing services market include Eurofins Scientific SE (Luxembourg), Intertek Group plc (UK), ICON plc (Ireland), IQVIA Inc. (US), Labcorp Holdings Inc. (US), Thermo Fisher Scientific Inc. (US), SGS S.A. (Switzerland), Element Materials Technology (UK), Pace Analytical Services (US), Merck KGaA (Germany), and WuXi AppTec (China).

To know about the assumptions considered for the study download the pdf brochure

Eurofins Scientific SE (Luxembourg) has strengthened its position as a leading global analytical testing provider through its extensive laboratory network, diversified service portfolio, and geographic presence. Its capabilities span Life, BioPharma, Diagnostics, and Consumer & Technology Products, including genomic, clinical, environmental, and pharmaceutical testing. Its broad GMP laboratory network supports pharmaceutical, biopharmaceutical, and medical device companies. At the same time, continued expansion across Europe, North America, and Asia Pacific enhances its ability to deliver comprehensive and cost-efficient testing services globally.

WuXi AppTec (China) has established a strong position in analytical testing services by providing integrated analytical solutions from preclinical development through commercial supply. Its Analytical Services Unit supports pharmaceutical clients with method development and validation, stability studies, impurity research, large- and small-molecule analysis, microbial testing, and product characterization. The company’s dedicated Shanghai facility provides specialized laboratory infrastructure and advanced instrumentation for analytical development and stability testing. At the same time, its integrated capabilities across DMPK, bioanalytical, and toxicology services enable efficient project execution. WuXi AppTec’s analytical testing capabilities support both small- and large-molecule drug development programs, covering critical quality and characterization requirements.

Labcorp (US) provides comprehensive central laboratory services supporting pharmaceutical and biotechnology companies across clinical development programs. Its capabilities include biomarker and specialty testing, clinical chemistry, hematology, immunology, and molecular testing, supporting drug development and clinical research. In 2025, Labcorp expanded these capabilities through the acquisition of MLM Medical Labs, strengthening its laboratory footprint and biomarker and specialty testing capabilities for clinical trials. The expanded network across the U.S., Germany, and South Africa enhances Labcorp’s ability to support multinational clinical studies with standardized laboratory services. Its broad testing portfolio and global infrastructure enable Labcorp to support clinical trial sponsors ranging from emerging biotechnology companies to large pharmaceutical firms.

Market Ranking

The healthcare analytical testing services market is competitive, with key players including Eurofins Scientific SE (Luxembourg), WuXi AppTec (China), Labcorp (US), Thermo Fisher Scientific (US), and Charles River Laboratories (US). These companies strengthen their market positions through broad analytical testing portfolios, laboratory network expansion, service launches, acquisitions, and strategic collaborations. Eurofins maintains a strong position through its extensive global laboratory network and diversified testing capabilities, while WuXi AppTec and Labcorp continue expanding specialized analytical, bioanalytical, and clinical testing capabilities.

Related Reports:

Healthcare Analytical Testing Services Market by Test Type (Cell-based, Bioanalytical, Raw Material, Microbial, Batch-Release, Genomic, Method Development & Validation, Endotoxin), End User (Pharma, Biopharma, Medical Device, Clinic) - Global forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]